High failure rate of postmortem karyotyping after termination for fetal abnormality

Obstetrics and Gynecology

Volumn 88, Issue 5, 1996, Pages 859-862

  Kyle, Phillipa M ^a   Sepulveda, Waldo ^b   Blunt, Susan ^b   Davies, Graham ^b   Cox, Phillip M ^b   Fisk, Nicholas M ^b  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CADAVER; CHILDBIRTH; CYTOGENETICS; FETUS; FETUS DISEASE; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; PREGNANCY TERMINATION; PRIORITY JOURNAL;

EID: 0030296646     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00311-0     Document Type: Article

References (17)

1. 1. Luck CA. Value of routine ultrasound scanning at 19 weeks: A four-year study of 8894 deliveries. BMJ 1992;304:1474-8.
2. 2. Chitty LS, Hunt GH, Moore J, Lobb MO. Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. BMJ 1991;303:1165-9.
3. 3. Levi S, Schaaps JP, De Havay P, Coulon R, Defoort P. End-result of routine ultrasound screening for congenital anomalies: The Belgian Multicentric Study 1984-92. Ultrasound Obstet Gynecol 1995; 6:366-71.
4. 4. Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen O. Ultrasound screening and perinatal mortality: Controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet 1990;336:387-91.
5. 5. Nicolaides KH, Snijders RJM, Gosden CM, Berry C, Campbell S. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 1992;340:704-7.
6. 6. Bauld R, Sutherland GR, Bain D. Chromosome studies in investigation of stillbirths and neonatal deaths. Arch Dis Child 1974;49: 782-8.
7. 7. Smith A, Bannatyne P, Russell P, Ellwood D, den Dulk G. Cytogenetic studies in perinatal death. Aust N ZJ Obstet Gynaecol 1990;30:206-10.
8. 8. Persutte WH, Lenke RR. Failure of amniotic-fluid-cell growth: Is it related to fetal aneuploidy? Lancet 1995;345:96-7.
9. 9. Reid R, Sepulveda W, Kyle PM, Davies G. Amniotic fluid culture failure: Clinical significance and association with aneuploidy. Obstet Gynecol 1996;87:588-92.
10. 10. Isada NB, Pryde PG, Johnson MP, Hallak M, Blessed WB, Evans MI. Fetal intracardiac potassium chloride injection to avoid the hopeless resusitation of an abnormal abortus: I. Clinical issues. Obstet Gynecol 1992;80:296-9.
11. 11. Mueller RF, Sybert VP, Johnson J, Brown ZA, Chen W. Evaluation of a protocol for post-mortem examination of stillbirths. N Engl J Med 1983;309:586-90.
12. 12. Anonymous. Perinatal pathology [editorial]. Lancet 1984;i:431-2.
13. 13. Wigglesworth JS. Investigation of perinatal death. Arch Dis Child 1987;62:1207-8.
14. 14. Rushton DI. West Midlands Perinatal Mortality Survey, 1987. An audit of 300 perinatal autopsies. Br J Obstet Gynaecol 1991;98: 624-7.
15. 15. Rodgers CS, Creasy MR, Fitchett M, Pratt NR, Waters JJ. Solid tissue culture for cytogenetic analysis: A collaborative survey for the Association of Clinical Geneticists (ACC). J Clin Pathol 1996; 49:638-41.
16. 16. Association of Clinical Geneticists and UK National External Quality Assessment Scheme (NEQAS). Guidelines for clinical geneticists. Bristol, United Kingdom: Potten, Baber & Murray, 1994.
17. 17. Lazda EJ, Sams VR. The effect of gemeprost on the second trimester fetus: A histological study. Br J Obstet Gynaecol 1995;102:731-4.